Tilray | TRLY - Ebit

股票价格

8.54

每天变化

-0.58 -6.36%

每月一次

-17.57%

每年

818.28%

Q1 预测

9.24

金融业

USD

USD 2.1B

现金及等价物

USD 264.83M

USD 164.37M

USD 729.32M

USD 259.32M

USD 640.95M

USD -20.01M

USD 8.37M

USD 2.84K

EPS每股收益

USD -0.41

股本和储备

USD 1.58B

USD 57.47M

债务利息支出

USD 6.7M

USD 12.83M

USD 268.59M

USD 6.75B

USD -44.93M

USD 237.52M

USD -20.01M

普通股股本

USD 116.52M

11.57

USD -39.96M

USD 217.51M

销售和管理费用

USD 24.85M

USD 282.79M

贸易债权人

USD 114.5M

应收帐款人

USD 109.07M

	Ebit	更改		日
Acasti Pharma	USD -3.7M		1.13M	2024-12
Akebia Therapeutics	USD -5.45M		9.4M	2025-12
Alaunos Therapeutics	USD -1.19M		148K	2025-09
Aurora Cannabis	CAD -35.79M		8.96M	2025-12
Avita Medical	AUD -10.39M		1.72M	2025-12
Canopy Growth	CAD -12.66M		1.64M	2025-12
Cronos Group	USD -7.06M		62.31M	2025-12
Dianthus Therapeutics	USD -69.54M		29.25M	2025-12
Divis Laboratories Ltd	INR 7.72B		30M	2025-12
Ionis Pharmaceuticals	USD -215M		54.82M	2025-12
IQVIA Holdings	USD 2.68B		2.1B	2025-12
Knight Therapeutics	CAD 6.21M		3.27M	2025-12
Moderna	USD -857M		597M	2025-12
Organigram Holdings	CAD -20.13M		7.92M	2025-12
Organon & Co	USD 388M		28M	2025-09
Revvity	USD 145.83M		47.49M	2025-12
Tectonic Therapeutic	USD -21.52M		374K	2025-12
Tilray	USD -20.01M		9.34M	2025-09
Viatris	USD -157.5M		392M	2025-12
Xeris Pharmaceuticals	USD 16.77M		8.88M	2025-12
Zealand Pharma A/S	-707.05M		245.73M	2025-12